Stimulatory effect of imeglimin on incretin secretion

Stimulatory effect of imeglimin on incretin secretion

ABSTRACT Aims/Introduction Imeglimin is a new antidiabetic drug structurally related to metformin. Despite this structural similarity, only imeglimin augments glucose‐stimulated insulin secretion (GSIS), with the mechanism underlying this effect remaining unclear. Given that glucose‐dependent insuli...

Full description

Bibliographic Details
Main Authors: Quan Yingyue, Kenji Sugawara, Harumi Takahashi, Norihide Yokoi, Kento Ohbayashi, Yusaku Iwasaki, Susumu Seino, Wataru Ogawa
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Journal of Diabetes Investigation
Subjects:
Glucagon‐like peptide‐1
Glucose‐stimulated insulin secretion
Imeglimin
Online Access:https://doi.org/10.1111/jdi.14001

Internet

https://doi.org/10.1111/jdi.14001

Similar Items